Free Trial

Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Down 0.7% - Should You Sell?

Ampliphi Biosciences logo with Medical background

Key Points

  • Ampliphi Biosciences shares fell by 0.7%, trading as low as $2.86 and last at $2.94, significantly below its typical volume with only 6,009 shares traded.
  • The company focuses on developing therapies for antibiotic-resistant infections using bacteriophage-based technology.
  • Ampliphi has two primary therapies in development: AB-SA01 for staphylococcus aureus infections and AB-PA01 for pseudomonas aeruginosa infections.
  • MarketBeat previews top five stocks to own in October.

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB - Get Free Report) shares dropped 0.7% on Tuesday . The stock traded as low as $2.86 and last traded at $2.94. Approximately 6,009 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 842,200 shares. The stock had previously closed at $2.96.

Ampliphi Biosciences Stock Down 3.7%

The company's 50 day moving average price is $2.57 and its two-hundred day moving average price is $1.98.

About Ampliphi Biosciences

(Get Free Report)

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.

Featured Stories

Should You Invest $1,000 in Ampliphi Biosciences Right Now?

Before you consider Ampliphi Biosciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.

While Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.